Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Hansa Biopharma Major Shareholding Notification 2021

Apr 7, 2021

3057_iss_2021-04-07_4873874e-8f93-411a-a271-5aa7cfd2b643.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer Hansa Biopharma AB

Holder

Handelsbanken Fonder AB

Instrument

Instrument Aktie SE0002148817
Before the transaction
Shares 2,223,483
Voting rights 2,223,483
Transaction
Date 06/04/2021
Limit for number of votes 5 %

After the transaction

Quantity Shares 2,232,823 Directly held voting rights 2,232,823 Indirectly held voting rights 0

Percentage

Directly held shares 4.87 % Directly held voting rights 5.005 % Indirectly held voting rights 0 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 5.005 % 2,232,823
paragraph, line 2 Instruments - FITA Ch. 4, section 2, first
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 5.005 % 2,232,823
Group total holdings
Voting rights 2,232,823
Percentage of voting rights 5.005
Published
07/04/2021 16:04
Contact
Name Fredrik Alheden
Phone 087013503 Email [email protected]

CLOSE PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25